MarketsSingle-source
2.0
Keros Therapeutics reports executive or director departure via 8-K filing
SEC EDGAR 8-K FilingsLO·US·about 4 hours ago
MarketsSingle-sourceLow
2.0
agilon health, inc. reports executive or director departure via 8-K filing
agilon health, inc. filed an 8-K form disclosing the departure of a director or officer and/or changes to compensatory arrangements. The filing indicates a leadership or governance transition, though specific details regarding the individual or the nature of the departure require review of the full exhibit.
Score Breakdown
Mosaic Score2.0
Confidence0.9
Significance0.1
Source credibility0.1
Related signals
8 foundMarketsSingle-source
2.0
Mitesco, Inc. files 8-K disclosing equity issuance and executive leadership changes
SEC EDGAR 8-K FilingsLO·US·about 14 hours ago
MarketsSingle-source
2.0
Ecominas Corp. files 8-K disclosing equity issuance and executive leadership changes
SEC EDGAR 8-K FilingsLO·US·1 day ago
MarketsSingle-source
2.0
iPower Inc. files 8-K regarding material definitive agreement
SEC EDGAR 8-K FilingsLO·US·1 day ago
MarketsSingle-source
2.0
APEX Tech Acquisition Inc. reports executive or director departure
SEC EDGAR 8-K FilingsLO·US·1 day ago
MarketsSingle-source
2.0
Blusky AI Inc. files 8-K disclosing material agreement and executive leadership changes
SEC EDGAR 8-K FilingsLO·US·about 10 hours ago
Markets | Finance | CorporateNotableSingle-source
5.1
innovative solutions & support inc files 8-k for material definitive agreement
SEC EDGAR 8-K FilingsLO·US·1 day ago
Finance | Markets | TradeNotableSingle-source
4.8
Generation Income Properties completes acquisition or disposition of assets
SEC EDGAR 8-K FilingsLO·US·1 day ago